Jushi: Canaccord Reiterates Price Target Following Financials Finally Being Released

Earlier this week, Jushi Holdings Inc. (CSE: JUSH) finally reported their first quarter 2021 and full year 2020 results after long delays by their auditor MNP. Jushi announced that their 2020 revenues increased 690% to $80.8 million year over year and gross profit came in at $43.1 million, with an adjusted EBITDA margin of ($3) million.

For the first quarter of 2021 the company had total revenues of $41.7 million, a 29% sequential rise, while the company had a gross profit of $20.1 million, and adjusted EBITDA of ($3) million.

Jushi only has six analysts who cover the name with a weighted 12-month price target of C$12.77, or a 78.33% upside. Three analysts have strong buy ratings and the other three have buy ratings. The street high sits at C$14 from two different analysts while the lowest is C$11.50.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

In Canaccord’s update note for Jushi, their analyst Bobby Burleson reiterates his U$10.00 (~C$12.61) price target and speculative buy rating. He says that both sets of numbers generally came in line with the pre-announced expectations but it shows that Jushi is, “delivering strong top-line while investing for further growth.”

The company also gave second-quarter guidance which came slightly below Canaccord’s previous estimates, calling the guidance “a little soft.” They however still have reiterated their rating and price target. Bobby also says that “guidance for 2021 is intact for now,” but wouldn’t be surprised if adjusted EBITDA came in slightly below the low end of the guidance.

The companies operations seem to be improving with Burleson writing, “JUSHF has improved its operational footprint and competitive position in its core markets of PA and IL.” In Jushi’s other states, Burleson points out that Virginia looks primed for “dramatic growth” and remains the company’s key differentiator. He also believes that the companies M&A pipeline remains robust as the company has recently announced multiple acquisitions to help plant flags in different states.

Below you can see Canaccord’s updated 2021 and 2022 estimates based on management guidance.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Building the $500M-a-Year Gold Mine | Victor Cantore – Amex Gold Mining

Building the Next 500,000-Ounce Gold Producer | Stephen Soock – Heliostar Metals

This Gold Explorer Is Making Its Biggest Bet | Brian Miller – Astra Exploration

Recommended

This Gold Discovery Just Keeps Getting Bigger | Roger Rosmus – Goliath Resources

Cardiol Expands MAVERIC Trial to Up to 150 Patients After Reaching Enrollment Target Early

Related News

Canopy Growth: Canaccord Lowers Price Target After “Uninspiring Quarter”

Last week, Canopy Growth Corp (TSX: WEED) (NASDAQ: CGC) reported their first fiscal quarter of...

Thursday, August 12, 2021, 10:54:00 AM

Numinus Wellness: Eight Capital Initiates With $1.10 Price Target

Last week, Eight Capital launched coverage on a basket of psychedelic companies. This comes after...

Monday, September 20, 2021, 02:41:00 PM

Antibe: Canaccord Cuts Price Target From $5.00 To $1.20 After Drug Pivot

In early August, Antibe Therapeutics Inc. (TSX: ATE) announced that they have paused their study...

Monday, October 18, 2021, 11:31:00 AM

TerrAscend: Canaccord Initiates Coverage With $4.25 Price Target, Buy Rating

On September 12, Canaccord Genuity initiated coverage on TerrAscend Corp (CSE: TER) with a buy...

Saturday, September 17, 2022, 05:17:00 PM

US Cannabis: Stifel Expects “Limited To No Sales Growth”

Earlier this month, Stifel-GMP came out with their US cannabis second quarter preview, calling the...

Monday, August 1, 2022, 01:17:00 PM